Human SARS-CoV2 (Omicron B.1.1.529 Variant) S-RBD IgM ELISA Kit

REQUEST MORE INFO
Catalogue No: abx392375
Price: US$797.50
(Size: 96 tests)

Click on the image to see the image legend

Available Options

* Size:

Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS Download Manual
Human SARS-CoV2 (Omicron B.1.1.529 Variant) S-RBD IgM ELISA Kit is a quantitative ELISA kit for detection of Human IgM antibodies against SARS-CoV2 (Omicron B.1.1.529 Variant) S-RBD in serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids.

Target Human SARS-CoV2 (Omicron B.1.1.529 Variant) S-RBD IgM
Reactivity Human
Tested Applications ELISA
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Storage Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
Validity The validity for this kit is 6 months.
Stability The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Test Range 1.563 ng/ml - 100 ng/ml
Sensitivity < 0.938 ng/ml
Detection Method Colorimetric
Assay Type Indirect
Assay Data Quantitative
Sample Type Serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids.
Availability Shipped within 5-12 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES.

The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.

Please note that our kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.
Research Articles on Human SARS-CoV2 (Omicron B.1.1.529 Variant) S-RBD IgM


Write a review

Tags:
(Click to show)